257 related articles for article (PubMed ID: 17370594)
21. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
Punt CJ
Ann Oncol; 2005 Jun; 16(6):845-6. PubMed ID: 15890668
[No Abstract] [Full Text] [Related]
22. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
Idelevich E; Greif F; Mavor E; Miller R; Kashtan H; Susmalian S; Ariche A; Brenner B; Baruch NB; Dinerman M; Shani A
Chemotherapy; 2009; 55(2):76-82. PubMed ID: 19077422
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
Sørbye H; Bruserud Y; Dahl O
Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
[No Abstract] [Full Text] [Related]
25. Recurrent priapism related to oxaliplatin infusion.
Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
[No Abstract] [Full Text] [Related]
26. Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
Gkioulbasanis I; Souglakos J; Vardakis N; Kotsakis A; Saridaki Z; Kentepozidis N; Polyzos A; Giassas S; Ignatiadis M; Bozionelou V; Christophylakis C; Georgoulias V
J BUON; 2007; 12(2):197-202. PubMed ID: 17600872
[TBL] [Abstract][Full Text] [Related]
27. A systemic analysis of S-1 regimens for treatment of patients with colon cancer.
Zhang E; Cao W; Cheng C; Huo BL; Wang YH
Asian Pac J Cancer Prev; 2014; 15(5):2191-4. PubMed ID: 24716955
[TBL] [Abstract][Full Text] [Related]
28. Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.
Mehta NN; Ravikumar R; Coldham CA; Buckels JA; Hubscher SG; Bramhall SR; Wigmore SJ; Mayer AD; Mirza DF
Eur J Surg Oncol; 2008 Jul; 34(7):782-6. PubMed ID: 18160247
[TBL] [Abstract][Full Text] [Related]
29. Selecting regimens in advanced colon cancer.
Diasio RB
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-19-24. PubMed ID: 23570094
[No Abstract] [Full Text] [Related]
30. Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.
Liu JH
Clin Colorectal Cancer; 2004 Sep; 4(3):204-5. PubMed ID: 15377404
[No Abstract] [Full Text] [Related]
31. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
[TBL] [Abstract][Full Text] [Related]
32. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
[No Abstract] [Full Text] [Related]
33. [Management for adverse events associated with FOLFIRI plus cetuximab or panitumumab].
Masuishi T; Muro K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():587-91. PubMed ID: 25831828
[No Abstract] [Full Text] [Related]
34. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy.
Ron DA; Vera R; Labandeira CM; Manrique MCA; Núñez MÁ; Cid NG; Mata JG; Montes AF
Clin Transl Oncol; 2020 Aug; 22(8):1205-1215. PubMed ID: 31898053
[TBL] [Abstract][Full Text] [Related]
35. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
36. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
[No Abstract] [Full Text] [Related]
37. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin (Eloxatin) for advanced colon cancer.
Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
[No Abstract] [Full Text] [Related]
39. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
40. [Safety and efficacy of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) in Chinese patients with advanced colorectal cancer].
Song Y; Li WW; Huang J
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):380-383. PubMed ID: 28535657
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]